Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Varicella-zoster virus (VZV) glycoprotein antigens are structural proteins embedded in the viral envelope, playing essential roles in viral entry, cell-to-cell spread, immune evasion, and pathogenesis. The most prominent VZV glycoproteins include glycoprotein E (gE), glycoprotein B (gB), and the gH/gL heterodimer. These glycoproteins are major targets for neutralizing antibodies and are used in diagnostic assays and vaccine development.
Neutralization of viral entry, inhibition of cell-to-cell spread
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Varicella-zoster Virus Glycoprotein Antigens (VZV Glycoproteins).